Page last updated: 2024-08-21

molybdenum disulfide and Experimental Neoplasms

molybdenum disulfide has been researched along with Experimental Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fu, C; Meng, X; Ren, J; Ren, X; Shao, H; Tan, L; Wu, Q; Zhao, Y1
Geng, B; Li, P; Li, X; Pan, D; Qin, H; Shen, L; Shen, W; Wang, X; Wu, K; Zheng, F1
Cui, W; Gong, H; Li, Z; Liang, C; Liu, T; Liu, Z; Shi, X; Sun, B; Wang, C1

Other Studies

3 other study(ies) available for molybdenum disulfide and Experimental Neoplasms

ArticleYear
Interlayer expansion of 2D MoS
    Chemical communications (Cambridge, England), 2018, Dec-11, Volume: 54, Issue:99

    Topics: Animals; Biocompatible Materials; Combined Modality Therapy; Disulfides; Hep G2 Cells; Heterografts; Humans; Hyperthermia, Induced; Infrared Rays; Mice; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Molybdenum; Nanostructures; Neoplasms, Experimental; Phototherapy; Spectrophotometry, Ultraviolet; Spectroscopy, Near-Infrared; X-Ray Diffraction

2018
Carbon dot-sensitized MoS
    Nanoscale, 2019, Apr-11, Volume: 11, Issue:15

    Topics: Animals; Carbon; Cell Line, Tumor; Combined Modality Therapy; Disulfides; Humans; Hyperthermia, Induced; Mice; Molybdenum; Neoplasm Metastasis; Neoplasms, Experimental; Photoacoustic Techniques; Photochemotherapy; Quantum Dots; Tomography, X-Ray Computed; Xenograft Model Antitumor Assays

2019
Combined photothermal and photodynamic therapy delivered by PEGylated MoS2 nanosheets.
    Nanoscale, 2014, Oct-07, Volume: 6, Issue:19

    Topics: Cell Line, Tumor; Cell Survival; Chlorophyllides; Coated Materials, Biocompatible; Combined Modality Therapy; Diffusion; Disulfides; Humans; Light; Metal Nanoparticles; Molybdenum; Nanocapsules; Neoplasms, Experimental; Photochemotherapy; Photosensitizing Agents; Phototherapy; Polyethylene Glycols; Porphyrins; Treatment Outcome

2014